Companies:
50,246
Total Market Cap:
139193740943180.46
Virax Biolabs Group Limited
NASDAQ: VRAX
Healthcare
Biotechnology
Global Rank
#44965
Country Rank
#1135
Market Cap
3.67 M
Price
0.845
Change (%)
4.33%
Volume
77,633
Virax Biolabs Group Limited's latest marketcap:
3.67 M
As of 08/03/2025, Virax Biolabs Group Limited's market capitalization has reached $3.67 M. According to our data, Virax Biolabs Group Limited is the 44965th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.67 M |
| Revenue (ttm) | 6,331 |
| Net Income (ttm) | -6,061,247 |
| Shares Out | 4.34 M |
| EPS (ttm) | -1.62 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 02/05/2025 |
Market Cap Chart
Data Updated: 08/03/2025
Virax Biolabs Group Limited's yearly market capitalization.
Virax Biolabs Group Limited has seen its market value drop from $9.36 M to $3.67 M since 2022, representing a total decrease of 60.81% and an annual compound decline rate (CAGR) of 30.30%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/03/2025 | $3.67 M | -62.44% | 44965 |
| 12/31/2024 | $9.77 M | 269.37% | 38100 |
| 12/29/2023 | $2.64 M | -71.76% | 41218 |
| 12/30/2022 | $9.36 M | 36185 |
Company Profile
Virax Biolabs Group Limited was founded in 2013 in United Kingdom.
The company went public on 07/21/2022
on the Nasdaq Stock Market.
With 19 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Virax Biolabs Group Limited's (VRAX) current market cap?As of 08/03/2025, Virax Biolabs Group Limited (including the parent company, if applicable) has an estimated market capitalization of $3.67 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Virax Biolabs Group Limited (VRAX) rank globally by market cap?Virax Biolabs Group Limited global market capitalization ranking is approximately 44965 as of 08/03/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.